Literature DB >> 2579023

Identification with monoclonal antibodies of different regions of human plasma fibronectin, including that which interacts with human monocyte fibronectin receptors.

J K Czop, J L Kadish, D M Zepf, K F Austen.   

Abstract

The determinant specificities of five monoclonal anti-fibronectin antibodies, designated BC7, CE9, BD4, AB3 and CPG1, were defined and mapped within intact human plasma fibronectin by immunoblot analyses with defined fragments of fibronectin. The latter were derived by tryptic, chymotryptic or cathepsin D digestion of the intact molecule and fractionated by DE-cellulose chromatography and gelatin and/or heparin affinity chromatography. Monoclonal BC7 recognizes intrachain disulphide-formed determinants within the 27,000 MW N-terminal domain; monoclonal CE9 recognizes determinants within an 18,000 MW fragment immediately adjacent to the carboxyl end of the gelatin-binding domain; monoclonal BD4 recognizes determinants within the cell-adhesive domain and within 150,000 of the N-terminus; monoclonal AB3 recognizes intrachain disulphide-formed determinants within 35,000 of the COOH-terminus of the intact molecule and detectable only on the alpha-chain polypeptide subunit; and monoclonal CPG1 recognizes determinants present on both chains of the intact molecule and immediately adjacent to the interchain disulphide bonds at the COOH-terminus. None of the epitopes recognized by these monoclonal antibodies is present at alternative regions of the intact molecule. Fab fragments of each of these monoclonal antibodies were incubated with gelatin-coated sheep erythrocytes which had been reacted with a fixed amount of intact plasma fibronectin. When these target particles were incubated with monolayers of human monocytes and the resultant rosettes were quantitated, the Fab fragments of BD4 markedly inhibited the proportion of monocytes binding these fibronectin-bearing targets, whereas none of the other Fab fragments had an inhibitory effect. Thus, monocyte fibronectin receptors which mediate adherence of fibronectin bridges to a target via gelatin recognize regions within the cell-adhesive domains of intact fibronectin but not regions at the amino or carboxy terminals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579023      PMCID: PMC1453542     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  The cold-insoluble globulin of human plasma: studies of its essential structural features.

Authors:  M W Mosesson; A B Chen; R M Huseby
Journal:  Biochim Biophys Acta       Date:  1975-04-29

2.  Cold-insoluble globulin, II[1,2]. Cyanogen bromide and plasminolysis fragments containing a label introduced by transamidation.

Authors:  F Jilek; H Hörmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1977-09

3.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Proteolytically derived fragments of human plasma fibronectin and their localization within the intact molecule.

Authors:  M B Furie; D B Rifkin
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

7.  The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components.

Authors:  M W Mosesson; R A Umfleet
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

8.  Location of a gelatin-binding region of human plasma fibronectin.

Authors:  M B Furie; A B Frey; D B Rifkin
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  Affinity of fibronectin to collagens of different genetic types and to fibrinogen.

Authors:  E Engvall; E Ruoslahti; E J Miller
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Fibronectin and phagocytosis.

Authors:  H Hörmann
Journal:  Blut       Date:  1985-11

2.  Carbohydrate heterogeneity of fibronectins. Synovial fluid fibronectin resembles the form secreted by cultured synoviocytes but differs from the plasma form.

Authors:  S Carsons; B B Lavietes; A Slomiany; H S Diamond; E Berkowitz
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

3.  Fibronectin in multiple sclerosis lesions.

Authors:  R A Sobel; M E Mitchell
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

4.  Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex.

Authors:  T Matsuyama; A Yamada; J Kay; K M Yamada; S K Akiyama; S F Schlossman; C Morimoto
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

5.  Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes.

Authors:  J K Czop; J Kay
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

6.  The vitronectin receptor serves as an accessory molecule for the activation of a subset of gamma/delta T cells.

Authors:  K Roberts; W M Yokoyama; P J Kehn; E M Shevach
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.